Synlogic Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Updates
March 29, 2023 06:40 ET
|
Synlogic, Inc.
– Phenylketonuria (PKU) program on track for Phase 3 trial initiation in first half of 2023 – – Rare Pediatric Disease Designation granted for SYNB1934 for PKU and SYNB1353 for homocystinuria (HCU)...
Synlogic Receives Positive Opinion on Orphan Designation from the European Medicines Agency for SYNB1934 for the Treatment of Phenylketonuria
March 28, 2023 06:52 ET
|
Synlogic, Inc.
CAMBRIDGE, Mass., March 28, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today announced that the European Medicines...
Gene Synthesis Market Size & Share to Surpass $6.58 Billion by 2028 | Vantage Market Research
March 27, 2023 07:02 ET
|
Vantage Market Research
WASHINGTON, March 27, 2023 (GLOBE NEWSWIRE) -- Global Gene Synthesis Market is valued at USD 2.16 Billion in 2021 and is projected to reach USD 6.58 Billion by 2028 at a CAGR (Compound Annual Growth...
Gene Synthesis Market Size to Cross USD 14.2 Bn by 2033 with CAGR of 23.6% | Transparency Market Research
March 21, 2023 09:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, March 21, 2023 (GLOBE NEWSWIRE) -- According to Transparency Market Research, The global gene synthesis market stood at US$ 1.6 Billion in 2023 and the industry...
Synlogic Announces Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting
March 20, 2023 06:55 ET
|
Synlogic, Inc.
CAMBRIDGE, Mass., March 20, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, announced that positive data from the...
Telesis Bio to Present at Festival of Biologics Conference
March 16, 2023 06:00 ET
|
Telesis Bio
SAN DIEGO, March 16, 2023 (GLOBE NEWSWIRE) -- Telesis Bio Inc. (NASDAQ: TBIO), a leader in automated multi-omic and synthetic biology solutions, today announced Daniel Gibson, Ph.D., CTO and...
Synlogic to Present at the Oppenheimer 33rd Annual Healthcare Conference
March 08, 2023 07:00 ET
|
Synlogic, Inc.
CAMBRIDGE, Mass., March 08, 2023 (GLOBE NEWSWIRE) -- Synlogic, Inc. (Nasdaq: SYBX), the leading company advancing therapeutics based on synthetic biology, today announced that Aoife Brennan, M.B....
Synlogic To Present Three Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting
March 07, 2023 06:57 ET
|
Synlogic, Inc.
– Podium presentation on Phase 2 phenylketonuria (PKU) data – – Poster presentations on Phase 1 homocystinuria (HCU) data and HCU preclinical data – CAMBRIDGE, Mass., March 07, 2023 (GLOBE...
Enzymatic DNA Synthesis Market Worth $2.24 Billion, by 2028 with 45.1% CAGR – Global Report by The Insight Partners
February 28, 2023 08:28 ET
|
The Insight Partners
New York, Feb. 28, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Enzymatic DNA Synthesis Market Size, Share, Trends, Growth and Global Forecast to 2028 - COVID-19 Impact and Global...
LanzaTech and Tadweer to explore collaboration on conversion of waste to alternative fuels
February 16, 2023 08:30 ET
|
LanzaTech Inc.
ABU DHABI, United Arab Emirates, Feb. 16, 2023 (GLOBE NEWSWIRE) -- LanzaTech Global, Inc. ("LanzaTech"), an innovative Carbon Capture and Transformation ("CCT") company that transforms waste carbon...